** Special Summer Offer: Schedule a complimentary consultation. For more information call  303-789-7804 or email Amanda at AmandaH@asarchcenter.com

 

ABOUT SUBMENTAL FULLNESS

Submental fullness, sometimes referred to as “double chin”, is a common yet undertreated facial aesthetic condition. It can impact a broad range of adults, including both men and women, and can be influenced by several factors such as aging, genetics and weight gain, and is often resistant to diet and exercise alone.

If you’re bothered by submental fullness, you’re not alone. According to a 2014 survey conducted by the American Society for Dermatologic Surgery (ASDS):

  • 68% of people said they’re bothered by under-the-chin fullness, or double chin
  • People are just as bothered by under-the-chin fullness as they are by lines and wrinkles around and under their eyes

WHAT IS KYBELLA™?

KYBELLA™ is a prescription medicine used in adults to improve the appearance and profile of moderate to severe fat below the chin (submental fat), also called “double chin.” It is not known if KYBELLA™ is safe and effective for use outside of the submental area.

131718APPSeal_Diamond-1-600x571

ABOUT KYTHERA BIOPHARMACEUTICALS, INC.

KYTHERA Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of novel prescription products for the aesthetic medicine market. In addition to its lead product KYBELLA™, KYTHERA also licensed the worldwide rights to setipiprant, an early-stage potential treatment for hair loss.

KYTHERA’s longer-term strategy is to leverage its biotechnology and aesthetics experience to expand its product portfolio and pipeline. KYTHERA has submitted regulatory filings for ATX-101 in Canada, Switzerland and Australia. Find more information at www.kythera.com.